These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31261718)

  • 21. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29659554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
    Ravindran S; Rasool S; Maccalli C
    Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy.
    Wang B; Tian T; Kalland KH; Ke X; Qu Y
    Trends Pharmacol Sci; 2018 Jul; 39(7):648-658. PubMed ID: 29678298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Wnt/β-catenin pathway in ovarian cancer: a review.
    Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
    Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
    FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells and tumorigenesis.
    Zhu P; Fan Z
    Biophys Rep; 2018; 4(4):178-188. PubMed ID: 30310855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
    Nguyen VHL; Hough R; Bernaudo S; Peng C
    J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
    J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
    Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
    Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.
    Lecarpentier Y; Claes V; Vallée A; Hébert JL
    Clin Transl Med; 2017 Dec; 6(1):14. PubMed ID: 28405929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
    Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
    Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant regulation of Wnt signaling in hepatocellular carcinoma.
    Liu LJ; Xie SX; Chen YT; Xue JL; Zhang CJ; Zhu F
    World J Gastroenterol; 2016 Sep; 22(33):7486-99. PubMed ID: 27672271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.
    Prosperi JR; Goss KH
    Curr Drug Targets; 2010 Sep; 11(9):1074-88. PubMed ID: 20545611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ.
    Vallée A; Vallée JN; Lecarpentier Y
    J Mol Cell Cardiol; 2019 Aug; 133():36-46. PubMed ID: 31153873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells.
    Zhu J; Jiang Y; Yang X; Wang S; Xie C; Li X; Li Y; Chen Y; Wang X; Meng Y; Zhu M; Wu R; Huang C; Ma X; Geng S; Wu J; Zhong C
    Biochem Biophys Res Commun; 2017 Jan; 482(1):15-21. PubMed ID: 27836540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.